Ethema Health Corp (GRST)

[Bubae]

The son received his ownership from mom. That is 100 million shares for $25K or .00025 a share. Considering the enormous losses accumulated to date it would not have been a good idea for an insider to profit from all the hype last year. Also note that the Leons are owed $2.5 million and didn't take any of that in shares.

Considering that debt holders dropped dropped 1.3 billion new shares over 8 weeks in January and February 2020 it was nice of insiders to capitalize on the situation while the price remained at .0001 for 4 weeks. At that time most retail only knew that the, ARIA treatment center, the only one, was closed and the company acquired enormous debt as a result. January 2020 only started out with a bit more than 155 million outstanding shares.

For the fiscal year ended: December 31, 2020
https://sec.report/Document/0001721868-21-000220/

[color=red]"On June 1, 2020, the Company issued 100,000,000 shares to Ethan Leon, the son of our CEO in settlement of $25,000 of advances made to the Company by Eileen Greene and assigned to Ethan Leon,"

"During December 2020, the Company issued 4,000,000 Series A Preferred shares at par value of $0.01 per share to Eileen Greene, the spouse of our CEO, in settlement of $40,000 of advances made to the Company."[/color]


For the fiscal year ended: December 31, 2020
https://sec.report/Document/0001721868-21-000220/

On August 3, 2018, the Company changed the name of its subsidiary Seastone Delray Healthcare, LLC to Addiction Recovery Institute of America, LLC (“ARIA”).

West Palm Beach Treatment Operations

The Company treatment operations were based in our leased premises at 5400 East Avenue, West Palm Beach, Florida, USA.

This facility was operated until January 30, 2020, we have subsequently ceased operations at this facility and are currently exploring new treatment facility options.


For the quarterly period ended September 30, 2020
https://sec.report/Document/0001721868-20-000540/
12. Stockholders' deficit
a) Common shares
Authorized, issued and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding common shares of 1,577,862,975 and 155,483,897 as of March 31, 2020 and December 31, 2019, respectively.

Between January 6, 2020 and February 27, 2020, the Company issued 1,316,679,078 shares of common stock in terms of conversion notices received from convertible note holders. The shares issued were issued below par based on the market price of the stock on the date of conversion and were valued at $531,005.